Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-03

FDA Approved: GLIPIZIDE — Original Application (Advagen Pharma Limited)

View source ↗

Summary

The FDA approved Advagen Pharma Limited's original application for glipizide (generic). It confirms availability of a generic formulation indicated for type 2 d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glipizide (Glipizide)

Snippet

ORIG AP for GLIPIZIDE (GLIPIZIDE)